

S. Vincent Rajkumar, MD IMF Board Chair
Thomas Martin, MD
UCSF, Helen Diller Family Comprehensive Cancer Center
Wee Joo Chng, MD
National University of Singapore
María-Victoria Mateos, MD, PhD University of Salamanca
Vania Hungria, MD, PhD Santa Casa de São Paulo
Joseph Mikhael, MD, MEd, FRCPC, FACP IMF Chief Medical Officer
Sigurður Yngvi Kristinsson, MD, PhD University of Iceland
Philippe Moreau, MD University Hospital of Nantes
Shaji Kumar, MD Mayo Clinic
NIkhil Munshi, MD Dana-Farber Cancer Institute
Jesús San Miguel, MD, PhD University of Navarra
Sagar Lonial, MD, FACP
Winship Cancer Institute, Emory University
Saad Zafar Usmani, MD, MBA, FACP, FASCO
Memorial Sloan Kettering Cancer Center
Shared Experiences Help to Better Understand the Myeloma Journey
• Support Groups empower patients & care partners with information, insight & hope
• The IMF provides educational support to a network of over 150 myeloma specific groups
150+ US Support Groups
Over 200 Support Group Visits/year
Boston-Dana Farber, MA
Meets virtually on the 2nd Wednesday of each month at 5:30 PM
Prospect, CT
Meets virtually, with quarterly in-person on the 2nd Tuesday of each month at 6 PM
Greater Rhode Island
Meets hybrid on the 1st Wednesday of each month at 6 PM
Manchester, NH
Meets virtually on the 3rd Wednesday of each month at 6 PM
Cape Cod, MA
Meets in-person on the 2nd Tuesday of each month at 3 PM
Central MA
Meets hybrid on the 2nd Monday of each month at 6 PM
UConn (Farmington), CT
Meets virtual on the 1st Thursday of each month at 3:30 PM
Fairfield, CT
Meets virtually on the 1st Tuesday of each month at 7 PM
Portland, ME
Meets virtually on the 4th Wednesday of each month at 6 PM
Burlington, VT
Meets virtually on the 3rd Tuesday of each month at 5 PM
Special interest groups are designed as a supplemental support for specific populations of patients, in addition to their local Support Groups
MM Families
Founded in 2021
For patients & care partners with young children
Las Voces de Mieloma
Founded in 2022
For Spanish speaking patients & care partners
Living Solo & Strong
Founded in 2022
For patients without a care partner
Click here for more inf
Smolder Bolder
Founded in 2023
For smoldering myeloma patients & care partners
Veterans SIG
Founded in 2025
For those who served our country
High Risk Multiple Myeloma
Founded in 2023
For high-risk myeloma patients & care partners
Care Partners Only
Founded in 2024
For myeloma care partners only
Seamlessly matching patients to the latest clinical trials.
• Discover clinical trials tailored to your myeloma journey with the IMF.
• Filter by diagnosis, treatment, and location to find the best fit for you.
Clinical Trials Matching Engine Usage
& Family Seminars
• Boca Raton, FL – March 14 – 15
• Philadelphia, PA – May 2 – 3
• Los Angeles, CA – August 15 – 16
• Chicago, IL – October 3 – 4 Myeloma Community Workshops
Virtual-March 4-replay on myeloma.org • San Mateo, CA - March 29 • Atlanta, GA - April 5 • Edina, MN - April 26 • Denver, CO - June 21 • Virtual – July 29 – replay on myeloma.org
Seattle, WA - August 9
Waltham, MA - September 27
Raleigh-Durham, NC - November 15
Virtual – November 18
1. Ensure Access to Care: We advocate to ensure all myeloma patients have equitable, comprehensive, patient-centered care without insurance barriers that limit options or delay treatment initiation.
2. Eliminate Financial Barriers: We advocate for policies that allow myeloma patients access to treatments and supportive care interventions without facing financial hardships.
3. Advance Myeloma Research: We advocate for annual appropriations funding for myeloma research and the advancement of clinical trial eligibility and research protocols that ensure representation from diverse populations.
The IMF Grassroots Advocacy Program is multi-faceted and growing
• Advocacy Training & Leadership Development
• Policy and Legislative Education
• Grassroots Campaign Planning
• Health Policy Forums & Roundtables
• Advocacy Resource Development
• Storytelling and Personal Narratives